Published in

Sociedade Brasileira de Pneumologia e Tisiologia, Jornal Brasileiro de Pneumologia, 4(46), p. e20180255-e20180255, 2020

DOI: 10.36416/1806-3756/e20180255

Links

Tools

Export citation

Search in Google Scholar

Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

Journal article published in 2020 by Pedro Aguiar Jr1 ORCID, Felipe Roitberg ORCID, Gilberto Lopes Jr ORCID, Auro del Giglio ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload
Policy details
Data provided by SHERPA/RoMEO